(4S)-4-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-4-oxo-2-[4-[(4-phenoxyphenyl)sulfonylamino]butanoylamino]butanoyl]amino]-3-carboxypropanoyl]amino]butanoyl]amino]-4-methylpentanoyl]-methylamino]-5-[(2S)-2-(2-amino-2-oxoethyl)pyrrolidin-1-yl]-5-oxopentanoic acid

InChIKey	`PPLPLBVUEJOBPI-QZCIJFHVSA-N`
Compound Name	(4S)-4-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-4-oxo-2-[4-[(4-phenoxyphenyl)sulfonylamino]butanoylamino]butanoyl]amino]-3-carboxypropanoyl]amino]butanoyl]amino]-4-methylpentanoyl]-methylamino]-5-[(2S)-2-(2-amino-2-oxoethyl)pyrrolidin-1-yl]-5-oxopentanoic acid
Canonical SMILES	`CC(C)C[C@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CCCNS(=O)(=O)c1ccc(Oc2ccccc2)cc1)C(=O)N(C)[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1CC(N)=O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	7.3
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	10.2	IC50	ChEMBL
P45452	MMP13	Homo sapiens	Human	PF00045 PF00413 PF01471	6.4	IC50	ChEMBL
P39900	MMP12	Homo sapiens	Human	PF00045 PF00413 PF01471	6.3	IC50	ChEMBL
P50281	MMP14	Homo sapiens	Human	PF11857 PF00045 PF00413 PF01471	6.3	IC50	ChEMBL